Capricor Therapeutics | CAPR - Selling And Administration Expenses


Capricor Therapeutics reported $1.92M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Bioline Rx USD 858K 257K Mar/2026
Capricor Therapeutics USD 1.92M 446.47K Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Cytokinetics USD 104.4M 499K Jun/2026
Geron USD 35.42M 6.24M Mar/2026
Grifols EUR 320.45M 12.65M Dec/2025
Immunic USD 3.45M 451K Dec/2025
J&J USD 6.42B 381M Jun/2026
Plus Therapeutics USD 4.26M 779K Mar/2026
Prothena USD 12.67M 5.02M Mar/2026
PTC Therapeutics USD 73.89M 13.31M Mar/2026
Sarepta Therapeutics USD 107.6M 53.57M Jun/2026